Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 61177-44-4
2. Lithium Clavulanate
3. Clavulanate (lithium)
4. Lithium (2r,5r,z)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
5. Lithium;(2r,3z,5r)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
6. Chembl9306
7. Ncgc00096009-01
8. Lithium Clavulanoate
9. Einecs 262-639-3
10. Dsstox_cid_26012
11. Dsstox_rid_81288
12. Dsstox_gsid_46012
13. Dtxsid0046012
14. Hy-a0256b
15. Tox21_111547
16. Akos024258636
17. Lithium (2r-(2alpha,3(z),5alpha))-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo(3.2.0)heptane-2-carboxylate
18. Ms-20826
19. Cas-61177-44-4
20. Cs-0103016
21. C-6661
22. C16078
23. A923973
24. Clavulanate Lithium Salt, Antibiotic For Culture Media Use Only
25. Lithium(2r,5r,z)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
Molecular Weight | 205.1 g/mol |
---|---|
Molecular Formula | C8H8LiNO5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 205.05625079 g/mol |
Monoisotopic Mass | 205.05625079 g/mol |
Topological Polar Surface Area | 89.9 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 329 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Lithium Clavulanate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lithium Clavulanate, including repackagers and relabelers. The FDA regulates Lithium Clavulanate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lithium Clavulanate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lithium Clavulanate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lithium Clavulanate supplier is an individual or a company that provides Lithium Clavulanate active pharmaceutical ingredient (API) or Lithium Clavulanate finished formulations upon request. The Lithium Clavulanate suppliers may include Lithium Clavulanate API manufacturers, exporters, distributors and traders.
click here to find a list of Lithium Clavulanate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Lithium Clavulanate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lithium Clavulanate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lithium Clavulanate GMP manufacturer or Lithium Clavulanate GMP API supplier for your needs.
A Lithium Clavulanate CoA (Certificate of Analysis) is a formal document that attests to Lithium Clavulanate's compliance with Lithium Clavulanate specifications and serves as a tool for batch-level quality control.
Lithium Clavulanate CoA mostly includes findings from lab analyses of a specific batch. For each Lithium Clavulanate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lithium Clavulanate may be tested according to a variety of international standards, such as European Pharmacopoeia (Lithium Clavulanate EP), Lithium Clavulanate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lithium Clavulanate USP).
LOOKING FOR A SUPPLIER?